These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18680137)

  • 1. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma.
    Wu D; Ding Y; Wang S; Zhang Q; Liu L
    J Pathol; 2008 Oct; 216(2):167-75. PubMed ID: 18680137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
    Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer.
    Yang GL; Zhang LH; Bo JJ; Huo XJ; Chen HG; Cao M; Liu DM; Huang YR
    J Surg Oncol; 2012 Jul; 106(1):57-61. PubMed ID: 22237993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
    Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
    J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.
    Qian CN; Guo X; Cao B; Kort EJ; Lee CC; Chen J; Wang LM; Mai WY; Min HQ; Hong MH; Vande Woude GF; Resau JH; Teh BT
    Cancer Res; 2002 Jan; 62(2):589-96. PubMed ID: 11809714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
    J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma].
    Han F; Wang HY; Xia YF; Liu MZ; Zhao C; Lu TX
    Ai Zheng; 2007 Sep; 26(9):1015-9. PubMed ID: 17927864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma.
    Ho SY; Guo HR; Chen HH; Hsiao JR; Jin YT; Tsai ST
    Head Neck; 2004 Nov; 26(11):977-83. PubMed ID: 15390195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma.
    Chen MK; Lai JC; Chang CC; Chang JH; Chang YJ; Chen HC
    Head Neck; 2008 Aug; 30(8):1052-7. PubMed ID: 18442057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of endothelin A receptor expression to prognosis of nasopharyngeal carcinoma].
    Mai HQ; Zeng ZY; Zhang HZ; Hou JH; Mo HY; Guo X; Min HQ; Hong MH
    Ai Zheng; 2005 May; 24(5):611-5. PubMed ID: 15890108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
    Chen CL; Ou DL
    Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
    Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment.
    Tse KP; Tsang NM; Chen KD; Li HP; Liang Y; Hsueh C; Chang KP; Yu JS; Hao SP; Hsieh LL; Chang YS
    Clin Cancer Res; 2007 Nov; 13(21):6320-6. PubMed ID: 17975143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P; Lee CC; Chen LF
    Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of Tiam1 and Rac1 overexpression in nasopharyngeal carcinoma.
    Qi Y; Huang B; Yu L; Wang Q; Lan G; Zhang Q
    ORL J Otorhinolaryngol Relat Spec; 2009; 71(3):163-71. PubMed ID: 19506399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of Wnt-1 and beta-catenin in nasopharyngeal carcinoma.
    Wang FL; Guo X; Yuan TZ; Cao SM; Rao HL; Hou JH; Shao Q; Li NW; Hong MH
    Ai Zheng; 2009 Jan; 28(1):72-5. PubMed ID: 19448422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma].
    Zhao ZJ; Mo HY; Zhang CQ; Qi B; Li J; Hong MH; Mai HQ
    Ai Zheng; 2007 Nov; 26(11):1243-7. PubMed ID: 17991326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.